companydata.dkJJ PHARMA CONSULT ApS: Financial statements 2018
CVR: 33257635
JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -40,319 and a net result of DKK -42,594 compared with DKK 585,060 the year before. Equity amounted to DKK 1,963,614. The solvency ratio was 99.2%.
- Gross Profit
- -40,319 kr.
- Profit/Loss
- -42,594 kr.
- Equity
- 1,963,614 kr.
- Total Assets
- 1,979,922 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -40 t. | -43 t. | 2 mio. | 0 |
| 2017 | - | -18 t. | 585 t. | 2.1 mio. | - |
| 2016 | - | -45 t. | 315 t. | 1.6 mio. | - |
| 2015 | - | -17 t. | 582 t. | 1.4 mio. | - |
| 2014 | - | -23 t. | 920 t. | 934 t. | - |
Keep an eye on JJ PHARMA CONSULT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
JJ PHARMA CONSULT ApS has published its annual report for 2017. Gross profit came to DKK -18,228, and the net result was DKK 585,060.
About JJ PHARMA CONSULT ApS
JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity amounted to DKK 16,917,153.